Comparison of half effective dose of pump injection of deoxyepinephrine in obese and non obese pregnant women to prevent hypotension after spinal anesthesia in cesarean section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058519

Enrollment

Unknown

Registered

2022-04-10

Start date

2022-03-31

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Normal weight group:Deoxyadrenaline by body weight

Obesity group:Deoxyadrenaline by body weight

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Elective cesarean section for single fetus, ASA Class II, gestational aged >=37 weeks, height 150-170cm.

Exclusion criteria

Exclusion criteria: 1. Hypertension or preeclampsia, premature rupture of membranes, preexisting or gestational diabetes mellitus; 2. Intrauterine growth restriction, placenta previa, macroia, and any contraindications to spinal or epidural anesthesia such as local infection and/or bleeding.

Design outcomes

Primary

Measure	Time frame
Continuous infusion dose of deoxyepinephrine;	—

Secondary

Measure	Time frame
Incidence of hypotension;Bradycardia;	—

Countries

China

Contacts

Public ContactShen Yaohua

Hangzhou Linping District Maternal and Child Health Care Hospital

13989852772@163.com+86 13989852772

Outcome results